Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. CSC
10. BLK

Go back to Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.88 +0.08 (2.86%)
Previous Close $2.80    52 Week High $9.58 
Open $2.90    52 Week Low $2.34 
Day High $2.96    P/E N/A 
Day Low $2.81    EPS $-0.34 
Volume 379,154